The potential and limits of scrutiny in medical research

I have submitted  the following rapid response to the BMJ Editorial: The potential and limits of scrutiny in medical research: Thank you editor for welcoming ideas on this important matter. … Continue reading The potential and limits of scrutiny in medical research

“Drug development in psychiatry: 50 years of failure and how to resuscitate it”

This opinion by Professor David Nutt was published in Lancet Psychiatry, 11 February 2025: Table 1: Table 2:

The Myth of Unbiased Medical Education

In a recent blog I shared promotional material hosted by the BMJ. This material included videos of a symposium held at the Royal Society of Medicine: The Royal Society of … Continue reading The Myth of Unbiased Medical Education

‘Moving towards zero tolerance’

BMJ, 19 November 2024: Response by Amit Aggarwal, Executive Director Medical Affairs & Strategic Partnerships, The Association of the British Pharmaceutical Industry (ABPI): Dr Peter J Gordon and Dr Sian … Continue reading ‘Moving towards zero tolerance’

“Excessive claims by drug firms”

You may read this title and wonder who said it? If you have come across my blog before it would be reasonable to consider that it was said by me! … Continue reading “Excessive claims by drug firms”

‘And it needs to start at the top’

This letter, by bioethicist Mark Wilson, has been published in the current BMJ: The letter begins: “The mesh scandal is all too familiar. It joins a growing list of scandals … Continue reading ‘And it needs to start at the top’